Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Evolan Pharma AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 87,286 Less Arrow 85,494 Less Arrow 66,220
Financial expenses 612 More Arrow 763 Less Arrow 158
Earnings before taxes 28,744 Less Arrow 25,913 Less Arrow 21,017
EBITDA 36,082 Less Arrow 36,053 Less Arrow 27,554
Total assets 105,439 Less Arrow 91,697 Less Arrow 77,592
Current assets 89,168 Less Arrow 67,051 Less Arrow 44,226
Current liabilities 18,400 More Arrow 20,513 Less Arrow 19,208
Equity capital 81,912 Less Arrow 65,877 Less Arrow 47,401
- share capital 9 Equal arrow 9 Equal arrow 9
Employees (average) 28 More Arrow 29 Less Arrow 27

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 77.7% Less Arrow 71.8% Less Arrow 61.1%
Turnover per employee 3,117 Less Arrow 2,948 Less Arrow 2,453
Profit as a percentage of turnover 32.9% Less Arrow 30.3% More Arrow 31.7%
Return on assets (ROA) 27.8% More Arrow 29.1% Less Arrow 27.3%
Current ratio 484.6% Less Arrow 326.9% Less Arrow 230.2%
Return on equity (ROE) 35.1% More Arrow 39.3% More Arrow 44.3%
Change turnover 4,699 More Arrow 19,081 Less Arrow 6,132
Change turnover % 6% More Arrow 29% Less Arrow 10%
Chg. No. of employees -1 More Arrow 2 Less Arrow 0
Chg. No. of employees % -3% More Arrow 7% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.